MedPath
NMPA Approval

Metaraminol Bitartrate Injection

国药准字H20243727

May 15, 2024

Drug Information

重酒石酸间羟胺注射液

注射剂

1ml:10mg(按C₉H₁₃NO₂计)

化学药品

May 15, 2024

Company Information

Applicant Company

山西省大同市经济技术开发区第一医药园区

Manufacturing Company

山西省大同市经济技术开发区第一医药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.